Skip to main content
Accretion Pharmaceuticals IPO
5.51xsubscribed

Accretion Pharmaceuticals IPO

Pharmaceuticals & Drugs
listed
₹1.15LMin. investment

Accretion Pharmaceuticals Limited IPO Details

SectorPharmaceuticals & Drugs
Price range₹96.00 – ₹101
IPO type
SME
Lot size1200 shares
Issue size₹29Cr
Red Herring Prospectus
Read
Market cap
₹112.27CrLower than sector avg
RevenueApr 2023 - Mar 2024
₹33.66CrLower than sector avg
Growth rate3Y CAGR
22.88%

Accretion Pharmaceuticals IPO Subscription Status

Date
QIB
NII
Retail
Total
14-May-25
0.0 times (X)
0.0 times (X)
1.82 times (X)
0.86 times (X)
15-May-25
0.75X
0.0X
3.98X
1.92X
16-May-25
12.14X
0.0X
10.26X
5.51X

As on 14-May-25, 5:30 PM

Accretion Pharmaceuticals IPO Timeline

  1. Pre-apply
    12 May 2025
  2. Bid start
    14 May 2025
  3. Bid end
    16 May 2025
  4. Allotment
    19 May 2025
  5. Release of funds
    20 May 2025
  6. Demat transfer
    20 May 2025
  7. Listing
    21 May 2025

About Accretion Pharmaceuticals Limited

Incorporated in 2012, Accretion Pharmaceuticals is engaged in the business of manufacturing and marketing tablets, capsules, oral liquids, and external preparations (Ointment, Cream, Gel, Lotion & more). The company operates on a B2B model, serving domestic and export clients through direct sales and contract manufacturing. It earned 72.9% of its total revenue from the top 10 clients in FY24. The company has a manufacturing facility in Sanand, which has advanced machinery and efficient processes tailored to customer demand.

Checklist

Quality analysis
Revenue growth
Company valuation
Earnings expansion
Risk analysis
Debt to Equity ratio
Promoter holdings
Shares pledged
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Objectives of Accretion Pharmaceuticals Limited IPO

Working capital requirements
49.30%
The company will use ₹14.68 crore to fund working capital requirements
General corporate purposes
22.71%
The company will spend ₹6.7 crore towards its general corporate purposes.
Capex for upgradation
15.63%
₹4.65 crore allocated for capex to upgrade existing manufacturing facility.
Capex to purchase new equipment
9.04%
The company will use ₹2.69 crore to purchase new equipment/machineries.
Repayment or prepayment of borrowings
3.32%
The company will utilise ₹0.99 crore to repay or prepay some of its outstanding borrowings.

Compare

CompanyRevenue*3Y growthPATMarket capP/E ratioD/E ratio
This IPO₹33.66Cr22.88%₹3.87Cr₹112.27Cr29.011.02
This sector (avg.)₹1,331.47Cr0%₹193.4Cr₹10,914.84Cr60.870.43
₹52,578.44Cr---₹10,980.1Cr₹3,82,765.9Cr36.980.03
₹9,360Cr---₹2,191Cr₹1,60,635Cr64.600
₹11,516.09Cr---₹1,911.25Cr₹1,34,051.5Cr62.640.42

*Revenue for financial year 2023-24. Lower P/E and D/E ratios are generally preferred.

Accretion Pharmaceuticals IPO Contact Details

Company NameAccretion Pharmaceuticals Limited

How to apply for Accretion Pharmaceuticals IPO?

  1. Step 1

    Log in to your Upstox account to access IPO investments. Next, select the current IPO section.

  2. Step 2

    Specify IPO details. Enter the number of lots and the price you wish to apply for.

  3. Step 3

    Enter UPI ID. After entering your UPI ID, click submit. This will place your bid with the exchange.

  4. Step 4

    Mandate Notification. Your UPI app will receive a mandate notification to block funds.

  5. Step 5

    Approve Request. Your funds will be blocked once you approve the mandate request on your UPI.

Accretion Pharmaceuticals Limited IPO FAQs